Drug Type AAV based gene therapy |
Synonyms GQ 501, GQ501 |
Target |
Action stimulants, modulators |
Mechanism IL-1RA stimulants(interleukin 1 receptor antagonist stimulants), PRG4 modulators(proteoglycan 4 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Osteoarthritis | Preclinical | Germany | 07 Oct 2023 |